Company Statement: U.S. Federal Trade Commission clears Teva's acquisition of Cephalon
MLex Summary: Teva Pharmaceuticals has announced the Federal Trade Commission conditionally approved its buy of Cephalon. The companies must sell two new drug applications, one for cancer pain drug that is...To view the full article, register now.
Already a subscriber? Click here to view full article